Answers are grounded in this paper and cite their sources.
Adherence to follow-up guidelines and early detection are vital factors affecting the curability of relapsed cancer in CRC patients who undergo surgery. The first five years after surgery was found to be the most risky period for recurrence. Cost/effectiveness analysis indicate that follow-up protocols should be tailored to the risk of recurrence with the aim of identifying relapse when the disease is at an asymptomatic, presumably more curable stage.
No takes yet. Share an insight, caveat, or question.
Cristofaro et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: